Thyroid Hormone and Bone Mass: The Clinician's Dilemma
- 1 January 1994
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 4 (2) , 143-144
- https://doi.org/10.1089/thy.1994.4.143
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal womenJournal of Clinical Endocrinology & Metabolism, 1994
- Change in Bone Mineral Density in Patients with Hyperthyroidism after Attainment of Euthyroidism by Dual Energy X-Ray AbsorptiometryThyroid®, 1994
- Influence of Clinical Characteristics and Parameters Associated with Thyroid Hormone Therapy on the Bone Mineral Density of Women Treated with Thyroid HormoneThyroid®, 1994
- The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in ratsCalcified Tissue International, 1993
- Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humansJournal of Clinical Endocrinology & Metabolism, 1993
- Prevalence of Fractures in Postmenopausal Women with Thyroid DiseaseThyroid®, 1993
- Bone Mineral Density in Children and Adolescent Females Treated with High Doses of L·ThyroxineHormone Research, 1993
- Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidismJournal of Clinical Endocrinology & Metabolism, 1992
- REDUCED FOREARM BONE MINERAL CONTENT AND BIOCHEMICAL EVIDENCE OF INCREASED BONE TURNOVER IN WOMEN WITH EUTHYROID GOITRE TREATED WITH THYROID HORMONEClinical Endocrinology, 1990
- Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal womenJAMA, 1988